Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Montalescot

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1996
[Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients]J Blacher, G Montalescot, A Ankri, et al.
The American Journal of Cardiology|October 7, 1998
Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failureG Montalescot, G Drobinski, P Meurin, et al.
American Heart Journal|December 1, 1990
Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteriesG Montalescot, G Drobinski, J Maclouf, et al.
International Journal of Cardiology|July 1, 1993
Coronary artery vasomotion in cardiac transplant patients with normal coronary angiogramsG Drobinski, M Desruennes, R ViFane, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1992
[Peripheral calcific embolism after percutaneous mitral valvuloplasty]G Montalescot, G Drobinski, D Thomas, et al.
Clinical Pharmacology and Therapeutics|February 18, 1998
Population pharmacokinetic-pharmacodynamic analysis of fluindione in patientsF Mentré, F Pousset, E Comets, et al.
Circulation|November 1, 1990
Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheepG Montalescot, E Lowenstein, M L Ogletree, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 28, 2006
[The value of active stents for coronary angioplasty in patients with chronic renal failure]G Phélippeau, C Le Feuvre, G Helft, et al.
Heart (British Cardiac Society)|December 18, 2004
Description of modern practices of percutaneous coronary intervention and identification of risk factors for adverse outcome in the French nationwide OPEN registryG Montalescot, B Chevalier, M C Dalby, et al.
International Journal of Cardiology|August 8, 1997
Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery diseaseG Montalescot, A Ankri, B Chadefaux-Vekemans, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1996
[Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients]J Blacher, G Montalescot, A Ankri, et al.
The American Journal of Cardiology|October 7, 1998
Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failureG Montalescot, G Drobinski, P Meurin, et al.
American Heart Journal|December 1, 1990
Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteriesG Montalescot, G Drobinski, J Maclouf, et al.
International Journal of Cardiology|July 1, 1993
Coronary artery vasomotion in cardiac transplant patients with normal coronary angiogramsG Drobinski, M Desruennes, R ViFane, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1992
[Peripheral calcific embolism after percutaneous mitral valvuloplasty]G Montalescot, G Drobinski, D Thomas, et al.
Clinical Pharmacology and Therapeutics|February 18, 1998
Population pharmacokinetic-pharmacodynamic analysis of fluindione in patientsF Mentré, F Pousset, E Comets, et al.
Circulation|November 1, 1990
Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheepG Montalescot, E Lowenstein, M L Ogletree, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 28, 2006
[The value of active stents for coronary angioplasty in patients with chronic renal failure]G Phélippeau, C Le Feuvre, G Helft, et al.
Heart (British Cardiac Society)|December 18, 2004
Description of modern practices of percutaneous coronary intervention and identification of risk factors for adverse outcome in the French nationwide OPEN registryG Montalescot, B Chevalier, M C Dalby, et al.
International Journal of Cardiology|August 8, 1997
Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery diseaseG Montalescot, A Ankri, B Chadefaux-Vekemans, et al.
Pageof 15